Literature DB >> 31668121

Lysosomotropic beta blockers induce oxidative stress and IL23A production in Langerhans cells.

Gerrit Müller1, Charlotte Lübow1,2, Günther Weindl1,2.   

Abstract

Oxidative stress and Th17 cytokines are important mediators of inflammation. Treatment with beta-adrenoceptor (ADRB) antagonists (beta-blockers) is associated with induction or aggravation of psoriasis-like skin inflammation, yet the underlying mechanisms are poorly understood. Herein, we identify lysosomotropic beta-blockers as critical inducers of IL23A in human monocyte-derived Langerhans-like cells under sterile-inflammatory conditions. Cytokine release was not mediated by cAMP, suggesting the involvement of ADRB-independent pathways. NFKB/NF-κB and MAPK14/p38 activation was required for propranolol-induced IL23A secretion whereas the NLRP3 inflammasome was dispensable. MAPK14 regulated recruitment of RELB to IL23A promoter regions. Without affecting the ubiquitin-proteasome pathway, propranolol increased lysosomal pH and induced a late-stage block in macroautophagy/autophagy. Propranolol specifically induced reactive oxygen species production, which was critical for IL23A secretion, in Langerhans-like cells. Our findings provide insight into a potentially crucial immunoregulatory mechanism in cutaneous dendritic cells that may explain how lysosomotropic drugs regulate inflammatory responses. ABBREVIATIONS: ATF: activating transcription factor; DC: dendritic cell; ChIP: chromatin immunoprecipitation; gDNA: genomic DNA; IL: interleukin; LAMP1: lysosomal associated membrane protein 1; LC: Langerhans cell; LPS: lipopolysaccharide; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MoDC: monocyte-derived DC; MoLC: monocyte-derived Langerhans-like cell; mtDNA: mitochondrial DNA; NAC: N-acetyl-L-cysteine; NLRP3: NLR family pyrin domain containing 3; PBMC: peripheral blood mononuclear cell; PI: propidium iodide; PYCARD/ASC: PYD and CARD domain containing; qRT-PCR: quantitative real-time PCR; ROS: reactive oxygen species; SQSTM1/p62: sequestosome 1; TLR: Toll-like receptor; TRAF6: TNF receptor associated factor 6; TNF: tumor necrosis factor; Ub: ubiquitin.

Entities:  

Keywords:  Beta blockers; IL1; IL23A; MAPK14/p38; dendritic cells; inflammation; reactive oxygen species; skin

Mesh:

Substances:

Year:  2019        PMID: 31668121      PMCID: PMC7469640          DOI: 10.1080/15548627.2019.1686728

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  69 in total

1.  Ubiquitin-proteasome pathway as a new target for the prevention of restenosis.

Authors:  Silke Meiners; Michael Laule; Wim Rother; Christoph Guenther; Ines Prauka; Peter Muschick; Gert Baumann; Peter-Michael Kloetzel; Karl Stangl
Journal:  Circulation       Date:  2002-01-29       Impact factor: 29.690

2.  Evaluation of anti-inflammatory and atrophogenic effects of glucocorticoids on reconstructed human skin.

Authors:  Günther Weindl; Francesca Castello; Monika Schäfer-Korting
Journal:  Altern Lab Anim       Date:  2011-05       Impact factor: 1.303

3.  TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy.

Authors:  Chong-Shan Shi; John H Kehrl
Journal:  Sci Signal       Date:  2010-05-25       Impact factor: 8.192

4.  The ubiquitin-activating enzyme E1 as a novel therapeutic target for the treatment of restenosis.

Authors:  Zhexue Qin; Bin Cui; Jun Jin; Mingbao Song; Baoshang Zhou; Hongfeng Guo; Dehui Qian; Yongming He; Lan Huang
Journal:  Atherosclerosis       Date:  2016-02-13       Impact factor: 5.162

5.  V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation.

Authors:  Oliver Florey; Noor Gammoh; Sung Eun Kim; Xuejun Jiang; Michael Overholtzer
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

6.  Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase.

Authors:  Qiang Li; John F Engelhardt
Journal:  J Biol Chem       Date:  2005-11-14       Impact factor: 5.157

7.  Chloroquine promotes IL-17 production by CD4+ T cells via p38-dependent IL-23 release by monocyte-derived Langerhans-like cells.

Authors:  André Said; Stephanie Bock; Trim Lajqi; Gerrit Müller; Günther Weindl
Journal:  J Immunol       Date:  2014-11-10       Impact factor: 5.422

8.  Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs.

Authors:  J Ishizaki; K Yokogawa; F Ichimura; S Ohkuma
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

Review 9.  Drug-induced psoriasis. Recognition and management.

Authors:  N Tsankov; I Angelova; J Kazandjieva
Journal:  Am J Clin Dermatol       Date:  2000 May-Jun       Impact factor: 7.403

10.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production.

Authors:  Tatsuya Saitoh; Naonobu Fujita; Myoung Ho Jang; Satoshi Uematsu; Bo-Gie Yang; Takashi Satoh; Hiroko Omori; Takeshi Noda; Naoki Yamamoto; Masaaki Komatsu; Keiji Tanaka; Taro Kawai; Tohru Tsujimura; Osamu Takeuchi; Tamotsu Yoshimori; Shizuo Akira
Journal:  Nature       Date:  2008-10-05       Impact factor: 49.962

View more
  4 in total

Review 1.  Psoriasis between Autoimmunity and Oxidative Stress: Changes Induced by Different Therapeutic Approaches.

Authors:  Marija V Medovic; Vladimir Lj Jakovljevic; Vladimir I Zivkovic; Nevena S Jeremic; Jovana N Jeremic; Sergey B Bolevich; Ana B Ravic Nikolic; Vesna M Milicic; Ivan M Srejovic
Journal:  Oxid Med Cell Longev       Date:  2022-03-12       Impact factor: 6.543

2.  Metoprolol Inhibits Developmental Brain Sterol Biosynthesis in Mice.

Authors:  Luke B Allen; Károly Mirnics
Journal:  Biomolecules       Date:  2022-08-31

Review 3.  Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies.

Authors:  Jiangmei Xu; Hao Chen; Haisheng Qian; Fei Wang; Yunsheng Xu
Journal:  J Nanobiotechnology       Date:  2022-10-14       Impact factor: 9.429

4.  Low-intensity Pulsed Ultrasound regulates alveolar bone homeostasis in experimental Periodontitis by diminishing Oxidative Stress.

Authors:  Siqi Ying; Minmin Tan; Ge Feng; Yunchun Kuang; Duanjing Chen; Jie Li; Jinlin Song
Journal:  Theranostics       Date:  2020-08-01       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.